Stock comparison
Harmony Biosciences Holdings
Teleflex
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HRMY
Harmony Biosciences Holdings
Market cap
$1.75B
Sector
Healthcare
TFX
Teleflex
Market cap
$5.88B
Sector
Healthcare
Overall winner
Harmony Biosciences Holdings HRMY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HRMY | TFX | Winner |
|---|---|---|---|
| Warren Buffett | 67B | 27F | HRMY |
| Benjamin Graham | 60C | 35D | HRMY |
| Philip Fisher | 75B | 31F | HRMY |
| Peter Lynch | 62C | 1F | HRMY |
| Joel Greenblatt | 28F | 27F | HRMY |
| Charlie Munger | 62C | 23F | HRMY |
| Terry Smith | 67B | 19F | HRMY |
Side-by-side metrics
| Metric | HRMY | TFX |
|---|---|---|
| Market cap | $1.75B | $5.88B |
| P/E (TTM) | 11.8x | - |
| EV/EBIT | 6.4x | 21.9x |
| ROIC (TTM) | 12.5% | 2.73% |
| Gross margin | 76.55% | 53.27% |
| Net margin | 16.2% | -35.89% |
| Revenue CAGR 5y | 29.85% | -8.23% |
| EPS CAGR 5y | 46.45% | - |
| Debt / Equity | 0.2x | 0.1x |
| Dividend yield | 0.0% | 1.05% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HRMY leads on
- Net margin16.2%vs -35.89%+145%
- Revenue CAGR 5y29.85%vs -8.23%+128%
- ROIC (TTM)12.5%vs 2.73%+78%
- EV/EBIT6.4xvs 21.9x+71%
TFX leads on
- P/E (TTM)-vs 11.8x+148%
- Dividend yield1.05%vs 0.0%+100%
- Debt / Equity0.1xvs 0.2x+75%
- Market cap$5.88Bvs $1.75B+70%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.